Published in PLoS One on October 02, 2008
Temporal changes in cell marker expression and cellular infiltration in a controlled cortical impact model in adult male C57BL/6 mice. PLoS One (2012) 1.36
Drowning stars: reassessing the role of astrocytes in brain edema. Trends Neurosci (2014) 1.13
The dopaminergic system in autoimmune diseases. Front Immunol (2014) 1.02
ICV-transplanted human glial precursor cells are short-lived yet exert immunomodulatory effects in mice with EAE. Glia (2012) 0.93
Mechanisms of dendritic cell trafficking across the blood-brain barrier. J Neuroimmune Pharmacol (2011) 0.91
Immune adaptive microenvironment profiles in intracerebral and intrasplenic lymphomas share common characteristics. Clin Exp Immunol (2011) 0.84
Immune modulating peptides for the treatment and suppression of multiple sclerosis. Clin Immunol (2012) 0.84
Vascular, glial, and lymphatic immune gateways of the central nervous system. Acta Neuropathol (2016) 0.82
Heat-shock protein 70-dependent dendritic cell activation by 5-aminolevulinic acid-mediated photodynamic treatment of human glioblastoma spheroids in vitro. Br J Cancer (2011) 0.82
Dendritic cell migration in health and disease. Nat Rev Immunol (2016) 0.81
Innate-adaptive crosstalk: how dendritic cells shape immune responses in the CNS. Adv Exp Med Biol (2012) 0.80
Effect of morphine and SIV on dendritic cell trafficking into the central nervous system of rhesus macaques. J Neurovirol (2013) 0.80
Mapping the accumulation of co-infiltrating CNS dendritic cells and encephalitogenic T cells during EAE. J Neuroimmunol (2014) 0.77
Regulatory and T Effector Cells Have Overlapping Low to High Ranges in TCR Affinities for Self during Demyelinating Disease. J Immunol (2015) 0.76
Antibody blockade of CLEC12A delays EAE onset and attenuates disease severity by impairing myeloid cell CNS infiltration and restoring positive immunity. Sci Rep (2017) 0.75
Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell (2001) 13.24
Visualizing dendritic cell networks in vivo. Nat Immunol (2004) 7.13
Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity (2002) 4.87
Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain (2007) 3.88
CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ T(H)-17 cells in relapsing EAE. Nat Immunol (2007) 3.77
Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol (2004) 3.74
Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat Med (1999) 3.66
Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol (1988) 2.93
What is the blood-brain barrier (not)? Trends Immunol (2006) 2.42
Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology. Neuropathol Appl Neurobiol (2008) 2.32
Dendritic cells capable of stimulating T cells in germinal centres. Nature (1996) 1.90
Two subsets of dendritic cells are present in human cerebrospinal fluid. Brain (2001) 1.78
A life stage of particle-laden rat dendritic cells in vivo: their terminal division, active phagocytosis, and translocation from the liver to the draining lymph. J Exp Med (1996) 1.63
Mechanisms to explain the reverse perivascular transport of solutes out of the brain. J Theor Biol (2005) 1.59
Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cells. J Neuropathol Exp Neurol (2006) 1.52
Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology. Proc Natl Acad Sci U S A (2005) 1.50
Initiation of immune responses in brain is promoted by local dendritic cells. J Immunol (2004) 1.48
Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein. J Immunol (2005) 1.43
Pathology of cerebrospinal fluid and interstitial fluid of the CNS: significance for Alzheimer disease, prion disorders and multiple sclerosis. J Neuropathol Exp Neurol (1998) 1.41
Histopathology of multiple sclerosis lesions detected by magnetic resonance imaging in unfixed postmortem central nervous system tissue. Brain (1991) 1.26
Disproportionate recruitment of CD8+ T cells into the central nervous system by professional antigen-presenting cells. Am J Pathol (1999) 1.17
Recruitment of dendritic cells to the cerebrospinal fluid in bacterial neuroinfections. J Neuroimmunol (2002) 1.15
Thyroid hormone administration enhances remyelination in chronic demyelinating inflammatory disease. Proc Natl Acad Sci U S A (2004) 1.12
How to drain without lymphatics? Dendritic cells migrate from the cerebrospinal fluid to the B-cell follicles of cervical lymph nodes. Blood (2005) 1.12
Dendritic cells are present in ischemic brain after permanent middle cerebral artery occlusion in the rat. Stroke (2002) 1.05
Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets. J Neuropathol Exp Neurol (2008) 0.98
Purification and partial structural and functional characterization of mouse myelin/oligodendrocyte glycoprotein. J Neurochem (1992) 0.96
Toward a role of dendritic cells in the germinal center reaction: triggering of B cell proliferation and isotype switching. J Immunol (1999) 0.96
Interaction of Neisseria meningitidis with human meningeal cells induces the secretion of a distinct group of chemotactic, proinflammatory, and growth-factor cytokines. Infect Immun (2002) 0.93
The subarachnoid space as a site for precursor T cell proliferation and effector T cell selection in experimental autoimmune encephalomyelitis. J Neuroimmunol (1995) 0.93
Migration of antigen presenting cells from periphery to the peritoneum during an inflammatory response: role of chemokines and cytokines. FASEB J (2004) 0.77
Radiotherapy for glioblastoma in the elderly. N Engl J Med (2007) 5.64
Aquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entity. Neurology (2013) 2.59
Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis. Brain (2012) 2.39
Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis. Neurology (2014) 2.38
Papillary tumor of the pineal region. Am J Surg Pathol (2003) 2.13
MRI monitoring of neuroinflammation in mouse focal ischemia. Stroke (2006) 1.91
Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers. Arch Neurol (2010) 1.49
Collapsin response mediator proteins (CRMPs): involvement in nervous system development and adult neurodegenerative disorders. Mol Neurobiol (2003) 1.47
Acute-onset chorea, dystonia, and cardiac fibroelastoma in a child: a paraneoplastic association? Mov Disord (2012) 1.44
Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury. Brain (2010) 1.42
Mesenchymal stem cell conditioned media attenuates in vitro and ex vivo myocardial reperfusion injury. J Heart Lung Transplant (2010) 1.42
ER stress inhibits neuronal death by promoting autophagy. Autophagy (2012) 1.39
Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. A clinical and electrophysiological study of 20 patients. Brain (2002) 1.37
Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial. J Clin Oncol (2011) 1.34
In vivo effects of antibodies from patients with anti-NMDA receptor encephalitis: further evidence of synaptic glutamatergic dysfunction. Orphanet J Rare Dis (2010) 1.33
Metabotropic glutamate receptor type 1 autoantibody-associated cerebellitis: a primary autoimmune disease? Arch Neurol (2010) 1.28
The pattern and diagnostic criteria of sensory neuronopathy: a case-control study. Brain (2009) 1.26
Regulation of spine development by semaphorin3A through cyclin-dependent kinase 5 phosphorylation of collapsin response mediator protein 1. J Neurosci (2007) 1.25
From bone marrow to microglia: barriers and avenues. Trends Immunol (2008) 1.25
Prolonged response without prolonged chemotherapy: a lesson from PCV chemotherapy in low-grade gliomas. Neuro Oncol (2010) 1.24
Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator. J Neurol Sci (2004) 1.24
Thrombolysis for ischemic stroke in patients with old microbleeds on pretreatment MRI. Cerebrovasc Dis (2004) 1.19
Experimental allergic encephalomyelitis is inhibited in transgenic mice expressing human C-reactive protein. J Immunol (2002) 1.18
The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis. J Biol Chem (2008) 1.18
Factors influencing early admission in a French stroke unit. Stroke (2002) 1.16
Flt3+ macrophage precursors commit sequentially to osteoclasts, dendritic cells and microglia. BMC Immunol (2002) 1.14
MMP-9 deficiency affects axonal outgrowth, migration, and apoptosis in the developing cerebellum. Mol Cell Neurosci (2003) 1.14
Immunoglobulin G antibodies to the N-Methyl-D-aspartate receptor are distinct from immunoglobulin A and immunoglobulin M responses. Ann Neurol (2014) 1.13
NMO-IgG and Devic's neuromyelitis optica: a French experience. Mult Scler (2008) 1.12
How to drain without lymphatics? Dendritic cells migrate from the cerebrospinal fluid to the B-cell follicles of cervical lymph nodes. Blood (2005) 1.12
A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors. Endocr Relat Cancer (2007) 1.08
Afferent facilitation of corticomotor responses is increased by IgGs of patients with NMDA-receptor antibodies. J Neurol (2010) 1.06
A tumor growth inhibition model for low-grade glioma treated with chemotherapy or radiotherapy. Clin Cancer Res (2012) 1.06
Peri-ictal pseudoprogression in patients with brain tumor. Neuro Oncol (2011) 1.06
Matrix-binding vascular endothelial growth factor (VEGF) isoforms guide granule cell migration in the cerebellum via VEGF receptor Flk1. J Neurosci (2010) 1.05
Collapsin response mediator protein 1 mediates reelin signaling in cortical neuronal migration. J Neurosci (2006) 1.04
Calpain product of WT-CRMP2 reduces the amount of surface NR2B NMDA receptor subunit. J Neurochem (2006) 1.03
Delayed onset of a second paraneoplastic neurological syndrome in eight patients. J Neurol Neurosurg Psychiatry (2010) 1.02
Differential expression of CRMP1, CRMP2A, CRMP2B, and CRMP5 in axons or dendrites of distinct neurons in the mouse brain. J Comp Neurol (2005) 1.02
Semaphorin CD100 from activated T lymphocytes induces process extension collapse in oligodendrocytes and death of immature neural cells. J Immunol (2004) 1.02
Surface dynamics of GluN2B-NMDA receptors controls plasticity of maturing glutamate synapses. EMBO J (2014) 1.02
Ethical issues of informed consent in acute stroke. Analysis of the modalities of consent in 56 patients enrolled in urgent therapeutic trials. Cerebrovasc Dis (2005) 1.01
Decreased expression of glutamate transporters in genetic absence epilepsy rats before seizure occurrence. J Neurochem (2002) 0.98
Cultured autologous oral mucosal epithelial cell sheet (CAOMECS) transplantation for the treatment of corneal limbal epithelial stem cell deficiency. Invest Ophthalmol Vis Sci (2012) 0.97
IQGAP1 protein specifies amplifying cancer cells in glioblastoma multiforme. Cancer Res (2006) 0.96
Update on paraneoplastic neurological syndromes. Curr Opin Oncol (2009) 0.95
A role for the neuronal protein collapsin response mediator protein 2 in T lymphocyte polarization and migration. J Immunol (2005) 0.95
An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients. Mol Cancer (2010) 0.95
Processing and nuclear localization of CRMP2 during brain development induce neurite outgrowth inhibition. J Biol Chem (2008) 0.94
SNP array analysis reveals novel genomic abnormalities including copy neutral loss of heterozygosity in anaplastic oligodendrogliomas. PLoS One (2012) 0.94
CRMP3 is required for hippocampal CA1 dendritic organization and plasticity. FASEB J (2007) 0.94
Phosphorylation of CRMP2 (collapsin response mediator protein 2) is involved in proper dendritic field organization. J Neurosci (2012) 0.93
Phosphorylation of collapsin response mediator protein 2 on Tyr-479 regulates CXCL12-induced T lymphocyte migration. J Biol Chem (2009) 0.93
CRMP5 interacts with tubulin to inhibit neurite outgrowth, thereby modulating the function of CRMP2. J Neurosci (2010) 0.93
Potential side effect of propofol and sevoflurane for anesthesia of anti-NMDA-R encephalitis. BMC Anesthesiol (2014) 0.92
High pathogenicity of wild-type measles virus infection in CD150 (SLAM) transgenic mice. J Virol (2006) 0.91
Collapsin response mediator protein 4a (CRMP4a) is upregulated in motoneurons of mutant SOD1 mice and can trigger motoneuron axonal degeneration and cell death. J Neurosci (2010) 0.91
Choroid plexus controls brain availability of anti-HIV nucleoside analogs via pharmacologically inhibitable organic anion transporters. AIDS (2003) 0.90
Rat choroid plexuses contain myeloid progenitors capable of differentiation toward macrophage or dendritic cell phenotypes. Glia (2006) 0.90
Glutamatergic alterations in the cortex of genetic absence epilepsy rats. BMC Neurosci (2007) 0.88
Chemotherapy is the cornerstone of the combined surgical treatment of lung cancer with synchronous brain metastases. Lung Cancer (2006) 0.88
Devic's syndrome-like phenotype associated with thymoma and anti-CV2/CRMP5 antibodies. J Neurol Neurosurg Psychiatry (2007) 0.88
In vitro and in vivo models of cerebral ischemia show discrepancy in therapeutic effects of M2 macrophages. PLoS One (2013) 0.88
Autoimmune limbic encephalitis: an expanding concept. Lancet Neurol (2009) 0.87
Treatment of experimental autoimmune encephalomyelitis in rat by 1,25-dihydroxyvitamin D3 leads to early effects within the central nervous system. Acta Neuropathol (2003) 0.87
Meningeal T cells associate with diffuse axonal loss in multiple sclerosis spinal cords. Ann Neurol (2010) 0.87
Expression of collapsin response mediator proteins 1, 2 and 5 is differentially regulated in newly generated and mature neurons of the adult olfactory system. Eur J Neurosci (2005) 0.87
Telomere profiling: toward glioblastoma personalized medicine. Mol Neurobiol (2012) 0.87
Up-front temozolomide in elderly patients with glioblastoma. J Neurooncol (2010) 0.86
VEGF modulates NMDA receptors activity in cerebellar granule cells through Src-family kinases before synapse formation. Proc Natl Acad Sci U S A (2011) 0.86
Hypointense transcerebral veins at T2*-weighted MRI: a marker of hemorrhagic transformation risk in patients treated with intravenous tissue plasminogen activator. J Cereb Blood Flow Metab (2003) 0.86
Ipsilateral ptosis as main feature of tuberothalamic artery infarction. Neurol Sci (2009) 0.86
Expression of the onconeural CV2/CRMP5 antigen in thymus and thymoma. J Neuroimmunol (2006) 0.85
Early-stage investigations of ultrasmall superparamagnetic iron oxide-induced signal change after permanent middle cerebral artery occlusion in mice. Stroke (2009) 0.85
Complete loss of expression of the ANT1 gene causing cardiomyopathy and myopathy. J Med Genet (2011) 0.85
Acute headache followed by focal neuropsychological impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). J Stroke Cerebrovasc Dis (2010) 0.85
New targeted therapies in pituitary carcinoma resistant to temozolomide. Pituitary (2012) 0.85
Extensive myelitis associated with anti-NMDA receptor antibodies. BMC Neurol (2013) 0.84
Cortical glutamate metabolism is enhanced in a genetic model of absence epilepsy. J Cereb Blood Flow Metab (2006) 0.84
G303V tau mutation presenting with progressive supranuclear palsy-like features. Mov Disord (2011) 0.84
ATAD3B is a human embryonic stem cell specific mitochondrial protein, re-expressed in cancer cells, that functions as dominant negative for the ubiquitous ATAD3A. Mitochondrion (2012) 0.83
Transient alterations in granule cell proliferation, apoptosis and migration in postnatal developing cerebellum of CRMP1-/- mice. Genes Cells (2006) 0.83
HLA-DQ2+ individuals are susceptible to Hu-Ab associated paraneoplastic neurological syndromes. J Neuroimmunol (2010) 0.82
CRMP5 regulates generation and survival of newborn neurons in olfactory and hippocampal neurogenic areas of the adult mouse brain. PLoS One (2011) 0.82
Prediction of anaplastic transformation in low-grade oligodendrogliomas based on magnetic resonance spectroscopy and 1p/19q codeletion status. J Neurooncol (2015) 0.81
Mapping and kinetics of microglia/neuron cell-to-cell contacts in the 6-OHDA murine model of Parkinson's disease. Glia (2013) 0.81
Impairment of blood-cerebrospinal fluid barrier properties by retrovirus-activated T lymphocytes: reduction in cerebrospinal fluid-to-blood efflux of prostaglandin E2. J Neurochem (2005) 0.81
MRI assessment of the intra-carotid route for macrophage delivery after transient cerebral ischemia. NMR Biomed (2012) 0.81